Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-10-01
1993-11-09
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514381, 514384, 514396, 514397, 514383, A61K 3144, A61K 3141, A61K 31415
Patent
active
052603229
ABSTRACT:
A pharmaceutical composition comprising a non-peptide type angiotension II receptor antagonist is useful for the treatment of hyperuricemia.
REFERENCES:
Wong et al., J. Pharmacol & Exp. Ther., 252, 726-732 (1990).
Johnson et al., Drug News & Perspectives, 3, 337-351 (1990).
Ferris et al., Amer. J. Med. 44, 359-365 (1968).
Saito et al., J. Amer. Geriatric Soc. 26, 241-247 (1978).
Chiu et al., Biochem & Biophys. Res. Comm. 165, 196-203 (1989).
Koepke et al., Hypertension, 15, 841-847 (1990).
Wessesls et al., Medizinische Klinik, 69, 599-606 (1974).
Kamei Kazuo
Kanamaru Mitsutaka
Nakasima Mitsuyosi
Ohta Ikuo
DiPrima Joseph F.
Jordan Kimberly R.
Merck & Co. , Inc.
Nicholson William H.
North Robert J.
LandOfFree
Angiotension II antagonists in the treatment of hyperuricemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotension II antagonists in the treatment of hyperuricemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotension II antagonists in the treatment of hyperuricemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143127